Herpes Dating Platform Meet Positives Highlights Promising Prototype of a Herpes Research Tool

Chicago, Illinois -

Meet Positives, the country’s #1 dating website for people with herpes, is highlighting the recent development of a prototype herpes research tool that promises to speed up the development of human herpes treatments.

Dr. Jia Zhu, an immunologist, and virologist, at the Fred Hutchinson Cancer Center in Seattle, is leading a team of researchers that has developed a novel “skin-on-chip” platform. The experimental device in question is a small square constructed out of plexiglass in which human skin cells can be seeded and grown. The cells can then be infected with a dose of the herpes simplex viruses and the results can be extensively studied. The device is currently being prepared for screening antiviral compounds that can boost human herpes treatments.

The device has been under development and testing for over 5 years. Dr. Zhu’s broader vision for the device includes customizing herpes therapies for each patient by seeding the device with cells from a single individual. In the press release issued by Hutch News, Dr. Zhu talks about its potential by saying, “We all have different cells. We can get them and grow them. We can make different chips and we can compare them. It’s personalized medical research.”

Meet Positives founder and CEO, Jack Lombardi commented on Dr. Zhu’s work by saying, “We always welcome any update from the exciting world of science and technology that offers even the slightest glimmer of hope to those living with these life-changing afflictions. The news out of Fred Hutchinson Cancer Center is another scientific milestone that has us extremely excited about the future of herpes treatments. The creation of the experimental device and Dr. Zhu’s ideas on creating personalized herpes treatments are commendable. We can’t wait to see how this technology affects herpes research going forward.”

As one of the nation’s largest and fastest-growing herpes dating platforms, Meet Positives offers hope to more than 40 million people, or 1 in 5 American adults, who live with genital herpes, the most prevalent sexually transmitted infection in recent years. On the Meet Positives platform, herpes-positive singles can meet others who are sympathetic to their plight or, just like them, are facing the same challenges. In its mission statement, Meet Positives says that it was designed to be a safe space for STD-positive individuals to come together, freely express themselves, and find support in a strong community.

Meet Positive’s HSV community welcomes herpes-positive singles to learn more about their condition from others who have experienced the same feelings. It is also a source for getting the latest information about a possible cure for herpes, vaccination, and treatment options. Meet Positives also publishes several herpes drug reviews, side effects, and success stories that are submitted to the platform by its members. Finally, herpes singles who are feeling lonely and are seeking companionship can meet others, who understand what they are feeling and are also looking to move on with their lives, by signing up for the Meet Positives dating platform.

Meet Positives is the fastest-growing STD dating website and app for STD singles in major cities and rural areas across the United States, Canada, the United Kingdom, Europe, and Australia. The dating platform has thousands of registered members and hundreds of messages are sent back and forth between them every hour. The platform boasts a healthy gender ratio of 51% men and 49% women, ensuring that everyone has a chance to find someone to connect with, regardless of their gender or sexual preference. The Meet Positives app can match members by HSV, Herpes, HIV, HPV, or any other STD or STI in the user’s local area or the area they select. Meet Positives is indexed on all major search engines including Google, Bing, Yahoo, Yandex, Google Play, and Apple Store.

Readers can sign up for the Meet Positives herpes dating platform by heading over to its website or downloading its app from the Google Play Store. An iOS version of the app is currently in development.

SOURCE: Press Advantage [Link]